Summary The presence of a number of regulatory peptides (bombesin, gastrin, glucagon, somatostatin, calcitonin and ACTH) was compared in 30 typical carcinoid tumours and 27 well differentiated neuroendocrine carcinomas (atypical carcinoids) using conventional immunocytochemistry. Strong immunostaining for one or more peptide was observed in 97% of the typical carcinoids (29/30) whereas only 67% of the neuroendocrine carcinomas showed immunoreactivity. The peptide most frequently detected in typical carcinoids was bombesin (67%), while gastrin was more common in neuroendocrine carcinomas (44%). Immunoreactivity for more than one peptide was present in 33 tumours and in three cases, six different peptides were detected.
Lung tumours particularly small cell carcinoma and carcinoid tumours are noted for their ability to produce peptide hormones (Shalet et al., 1979) . Previous studies have tended to concentrate on typical carcinoids (Warren et al., 1984) but it has recently become apparent that up to 50% of bronchial carcinoid tumours (well differentiated neuroendocrine carcinoma) may show atypical features. It is important therefore to include such tumours when studying hormone production. A series of carcinoid tumours were studied with antisera to bombesin, gastrin, glucagon, somatostatin, calcitonin and ACTH to evaluate the frequency of peptide production in typical and well differentiated neuroendocrine carcinoma.
Materials and methods
This study was carried out on 57 cases of bronchial carcinoid tumours diagnosed at the Regional Cardiothoracic Centre, Wythenshawe Hospital, Manchester, between 1961 and 1986 . The identification and diagnosis of these tumours was based initially on the histologic appearance in sections stained by haematoxylin and eosin and the Grimelius method to demonstrate argyrophilia. The tumours were fixed in 10% neutral buffered formalin for at least 24h, routinely processed and embedded in paraffin wax. The diagnosis of atypical carcinoid (well differentiated neuroendocrine carcinoma) was based on the presence of one of the following factors; tumour necrosis, nuclear pleomorphism, an increased mitotic count, undifferentiated growth pattern, vascular and lymphatic invasion (Hasleton et al., 1986) . Frequently these features coexisted in any one case. Between one and three tumour blocks were selected for immunohistochemistry and 5pm thick serial paraffin sections were cut. All the cases were stained by the peroxidase-antiperoxidase (PAP) method or the indirect method (Sternberger, 1979) .
Sections were deparaffinized in xylene, transferred to alcohol and incubated in 0.5% hydrogen peroxide in methanol for 20min to block endogenous peroxidase. They were then rinsed in tris-HCl buffered saline, and overlayered with normal swine serum at 1/50 dilution for 20min to reduce background staining. The following primary rabbit antisera were used at the following dilutions: anti-gastrin (GS) 1/500, anti-glucagon (GLU), anti-somatostatin (SM) and anti- London. This antiserum recognises the C-terminal region of bombesin, cross-reacting 70% with synthetic porcine GRP and its C-terminal fragment, GRP (14-27) (Price et al., 1983) . The other antibodies except ACTH described below were purchased from the DAKO corporation, Denmark.
The swine anti-rabbit IgG serum and the peroxidase antiperoxidase complex were diluted 1/50 and 1/200 respectively. The sections were incubated with the first antibody overnight for 18h at 4°C, and then sequentially with the swine antirabbit and the peroxidase anti-peroxidase at their optimal dilutions for 1 h each at room temperature. After incubation with each antibody, the sections were rinsed in three changes of 0.1 M tris-HCl buffered saline (TBS) pH 7.6, 10 min each. All the antisera were diluted with the same buffer to which had been added 0.3% bovine serum albumin. The reaction was developed with a freshly prepared solution of 5mg 3-3' diaminobenzidine tetraydrochloride (DAB) in 10ml of 0.2M tris-HCI buffer, to which 100ul of 1% hydrogen peroxide in distilled water was added just before use. The slides were rinsed in TBS, counterstained with Mayer's haematoxylin, dehydrated, cleared and mounted with DPX.
The production and characterisation of the four monoclonal antibodies (MAbs) to ACTH have been described previously (White et al., 1985 (-) aFigures in brackets are the number of cases positive for one peptide only. (83%) showed positivity for at least one of the peptides studies. Twenty two of the positive cases showed immunoreactivity for 3 to 5 peptides which indicated the capability of these tumours for synthesizing and storing more than one peptide simultaneously. This feature has been described previously in normal neuroendocrine cells (Larsson, 1980) and bronchial carcinoids (Yang et al., 1983; Warren et al., 1984) . In a study of 25 bronchopulmonary carcinoids, Warren et al. (1984) have demonstrated up to eight hormones and their findings were supported by ultrastructural identification of a heterogeneous population of neurosecretory granules within single tumour cells. Multihormonal production has also been reported in small cell lung carcinoma cell lines which can secrete up to ten different peptides (Sorenson et al., 1981) .
The most frequently identified hormones in this study were bombesin (30 cases) followed by gastrin and calcitonin (27 and 26 cases) respectively. The finding of positive immunoreactivity for gastrin in a large number of our tumours is in contrast to three other studies which could not demonstrate the presence of gastrin (Yang et al., 1983; Tamai et al., 1983 & Martensson et al., 1987 . However, Warren et al., (1984) found gastrin in 15/25 (60%) bronchial carcinoids studied. Although there is no clear explanation for these results it could relate to the ability of the antisera to recognise the various molecular forms such as Gastrin 1-17, 1-34, 1-14 and 1-5 (Walsh & Grossman, 1975 ).
The results of immunostaining for bombesin are in agreement with previous reports. We observed immunoreactivity in 67% of typical carcinoids and 37% of atypical carcinoids in comparison with the study by Hamid et al. (1987) which showed moderately strong immunostaining in 35% of benign carcinoids and 22% of atypical carcinoids. The difference in the prevalence could relate to a difference in the specificity of the antisera, but this cannot be confirmed because the relevant specificity is not detailed in their study, and it may anyway relate to a difference in the ability of the antisera to recognise their epitopes in the precursor molecule. The relative immunoreactivity for bombesin was confirmed in the series of Hamid et al. (1987) by radioimmunoassay of tumour extracts from paraffin blocks suggesting that the immunostaining is a reliable approach for examining the expression of bombesin in bronchopulmonary carcinoids. Since high levels of bombesin have been reported in cell lines from small cell lung cancer (Moody et al., 1981; Wood et al., 1981; Sorenson et al., 1982) and in pulmonary carcinoid tumours (Bostwick et al., 1984; Martensson et al., 1987) .
Calcitonin, a 29 amino acid peptide, is predominantly found in thyroid C-cells and their derivative tumour, medullary carcinoma. In this study calcitonin was found in 46% of bronchopulmonary carcinoids. This is more frequent than recent reports where Warren et al. (1984) showed calcitonin immunoreactivity in 8% of bronchial carcinoids and Martensson et al. (1987) in 22% whereas Yang et al. (1983) were unable to demonstrate reactivity in seven tumours. Eighteen of the 26 cases with immunoreactivity for calcitonin in the present study were also positive for bombesin. The frequent demonstration of bombesin and calcitonin in our series parallels previous studies of normal endocrine cells of the bronchopulmonary tree (Cutz et al., 1981) and bronchopulmonary carcinoids (Warren et al., 1984) , and in normal and neoplastic thyroid C-cells. The finding of bombesin and calcitonin in separate cells in this study could indicate that the hormones are not co-secreted. The other frequent combinations of peptides in our series were gastrin and bombesin (18 cases), bombesin and ACTH (15 cases) and gastrin and calcitonin (14 cases).
ACTH was absent in the cases described by Warren et al. (1984) but was seem in 28% of tumours in the study of Martensson et al. (1987) . In common with these authors the present study shows ACTH was the second commonest pattern of immunostaining shown in bronchopulmonary carcinoids. The differences between these studies could well be due to the antibodies used, Warren et al. (1984) used Porcine anti-ACTH 1-39 antibodies at a dilution of 1/400, Martensson et al. (1987) used ACTH antisera at a dilution of 1/160 obtained from MILAB, Malmo, Sweden.
There is a suggestion that the production of calcitonin in bronchopulmonary carcinoid tumours may induce ossification of bronchial cartilage as well as bone formation in the tumour (Cooney et al., 1979) . Fifteen (26%) of the tumours in our study showed bone formation, 13 of which were positive for calcitonin. However, a further 12 positive cases showed no bone suggesting that no such correlation exists. It is not logical to expect calcitonin to induce ossification since bone is rare in medullary carcinoma of thyroid, which has high levels of calcitonin. Calcification and the presence of psammoma bodies have been reported in this tumour (Williams et al., 1966) .
Well differentiated neuroendocrine carcinomas ('atypical or malignant carcinoids') did not stain positively as frequently as typical carcinoids. One third of the neuroendocrine carcinomas were negative for hormones as opposed to 3% of the typical carcinoids. Somatostatin had the carcinoid syndrome and one showed features of ectopic growth hormone production (Shalet et al., 1979) . However, this study covers a period of 25 years and it is likely that endocrine manifestations were missed in the early years. Despite this it still appears there is a disparity between the clinical manifestations of bronchial carcinoid tumours and the large number of cases showing immunoreactivity. One explanation is that the pulmonary endothelial cells can detoxicate or degrade hormones so they do not reach the systemic circulation.
It should finally be noted that non-small cell carcinoma tumours can secrete hormones. Mooi et al. (1988) have shown in 11 cases, classified as large or squamous cell carcinoma, positive staining for neuron specific enolase, protein gene product 9.5 and C-terminal peptide of human pro-bombesin and chromogranin.
